Patient Stories

US | EN

United States | English
Canada | English
Canada | Français
Germany | Deutsch
Japan: | 日本語
Netherlands | Dutch
Spain | Español
United Kingdom | English
France | Français
Italy | Italian

Innovation
Back

How We Innovate

Where academic discovery, clinical insights, and patient experience come together.

Innovation Overview

Immunology Innovation Program

Our Pipeline

Partnered Programs

Clinical Trials

Publications

Clinical Research

Find information and resources to understand clinical research.

Explore clinical research

Case Studies

See how we're co-creating and accelerating innovation.

Start Exploring
Diseases & Patients
Back

Diseases and Patients

Behind every disease we study is a person waiting for answers.

Explore More

Diseases

Patient Voices

Patient Access

Untold Stories Podcast

Clinical Trials

Learn about argenx-sponsored clinical trials.

Explore Details
Myasthenia Gravis (MG)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Immune Thrombocytopenia (ITP)
Our Products
Back

Our Products

argenx’s product portfolio highlights its approved immunology therapies in the U.S.

Explore More

For HCPs

VYVGART
VYVGART Hytrulo

For Patients

VYVGART
VYVGART Hytrulo

My VYVGART® Path

Discover resources to support you along your treatment journey today.

Explore My VYVGART® Path
Who We Are
Back

Get to Know Us

The people, principles, and focus behind argenx.

argenx Overview

About Us

Our Leaders

Ethics & Responsibility

Meet argenx

One team. One culture. One focus. Watch entrepreneurial science come to life.

Watch How We Work

Grants

Funding for education, initiatives, and research.

See Our Impact
Newsroom
Back

argenx Newsroom

Company news, media resources, and the latest from argenx.

Explore Recent Updates

News & Media

Stories

argenx on LinkedIn

Get a closer look at our people and life at argenx.

Connect with Us
Investors
Back

Investors

Financial information, company updates, and resources for current and prospective argenx investors.

Explore Investors

Governance

Financials & Markets

Events & Presentations

Stock Information

Shareholder Meetings

AFM filings

SEC Filings

Analyst Coverage

Financial Reports

Access argenx financial reports and key updates on our performance and progress.

View Financial Reports
Join Us
Back

Join argenx

We’re all innovators on a continuous journey to learn, experiment, and discover on behalf of the patients we serve.

Get to Know Us

The argenx Way

Growth & Development

Rewards & Recognition

Job Openings

See current openings.

Explore Jobs

US | EN

United States | English
Canada | English
Canada | Français
Germany | Deutsch
Japan: | 日本語
Netherlands | Dutch
Spain | Español
United Kingdom | English
France | Français
Italy | Italian

Search Argenx

The Immunology Innovation Company | argenx
Newsroom
argenx Stories
Patient Stories

Our Story
Patient Stories
Pipeline
Immunology Innovation
Culture

argenx Stories

Our Story
Pipeline
Immunology Innovation
Culture

Patient Stories

Every person’s journey with a rare disease is unique — but resilience and resolve are traits these patients share. Explore the stories that inspire our team and help shape how we build our pipeline.

Patient Stories

Life with Myasthenia Gravis — First Time In Crisis

Discover

Patient Stories

One Mom’s Journey with Myasthenia Gravis

Discover

Patient Stories

The Loneliness of Life with Myasthenia Gravis

Discover

Patient Stories

Finding Support in The Myasthenia Gravis Community

Discover

Patient Stories

Managing the Toll of Myasthenia Gravis — It Takes a Team

Discover

Patient Stories

Myasthenia Gravis Diagnosis — a Six-Year Journey

Discover

Patient Stories

The Long Road to a Myasthenia Gravis Diagnosis

Discover

Patient Stories

When Career Goals Collide with Myasthenia Gravis

Discover

Patient Stories

Meet Jerry Williams: Connecting and Advocating for People with polymyositis

Discover

Interested in Learning More?

Get argenx news and updates right to your inbox

Join the team

Dare to do more with a thriving career at argenx.

Find your career

Get the latest news and info via our social media channels.

X
Facebook
LinkedIn
WhatsApp

Are you a U.S. resident?

If so, please confirm below to proceed to our U.S. product page. If not, return to our homepage.

Go Return to homepage (Global)

You are now leaving this website to visit another argenx website

Continue Cancel

You are now leaving the argenx website

This link will take you to a site maintained by a third party, which is responsible for its contents.

Ok Cancel

You are now leaving the argenx website

This link will take you to a site maintained by a third party, which is responsible for its contents.This website is intended for EU healthcare professionals only.

Ok Cancel

Please share just a few pieces of information so we can tailor the updates we send to you.

Please wait...

Not interested. Maybe later

Thank you for your interest!

Thank you for joining us on our journey to co-create potential therapies for people with severe autoimmune diseases. Together we discover.

Innovation
Diseases & Patients
Our Products
Who We Are
Newsroom
Investors
Join Us

To report an adverse event or product quality issue, please email us at reportnow@argenx.com or call us at 1-833-274-9411.

Are you a U.S. resident?

If so, please confirm below to proceed to our U.S. product page. If not, return to our homepage.

Go Return to homepage (Global)

You are now leaving this website to visit another argenx website

Continue Cancel

You are now leaving the argenx website

This link will take you to a site maintained by a third party, which is responsible for its contents.

Ok Cancel

You are now leaving the argenx website

This link will take you to a site maintained by a third party, which is responsible for its contents.This website is intended for EU healthcare professionals only.

Ok Cancel

Please share just a few pieces of information so we can tailor the updates we send to you.

Please wait...

Not interested. Maybe later

Thank you for your interest!

Thank you for joining us on our journey to co-create potential therapies for people with severe autoimmune diseases. Together we discover.

How We Innovate

Clinical Research

Case Studies

Diseases and Patients

Clinical Trials

Our Products

My VYVGART® Path

Get to Know Us

Meet argenx

Grants

argenx Newsroom

argenx on LinkedIn

Investors

Financial Reports

Join argenx

Job Openings

Patient Stories

Patient Stories

Patient Stories

Patient Stories

Patient Stories

Patient Stories

Patient Stories

Patient Stories

Patient Stories

Patient Stories

Interested in Learning More?

Join the team

Follow us

Are you a U.S. resident?

You are now leaving the argenx website

You are now leaving the argenx website

Subscribe

Thank you for your interest!

Are you a U.S. resident?

You are now leaving the argenx website

You are now leaving the argenx website

Subscribe

Thank you for your interest!